Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALZLIGHT Stage III - Study on the Effect of 40 Hz Non-Invasive Light Therapy System

NCT05260177 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT05260177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05260177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALZLIGHT Stage III - Study on the Effect of 40 Hz Non-Invasive Light Therapy System
Lead sponsor
Zealand University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 20, 2022
Completion date
December 1, 2028
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease